NutraIngredients big hitters for 2009
On our last publishing day of the year, NutraIngredients presents those stories that have had the biggest impact on you, our readers.
On our last publishing day of the year, NutraIngredients presents those stories that have had the biggest impact on you, our readers.
Flavour innovation has been driving new product development in a relatively mature European chocolate, chewing gum and sugar confectionery market with antioxdant-rich fruits coming to the fore, according to a new report from Leatherhead Food Research.
A new source of gamma-linolenic acid (GLA), claimed to be the “most concentrated, convenient and cost-effective source of GLA available,” has received acceptance from the Food and Drug Administration (FDA) allowing it to be marketed and sold as an...
The Middle Eastern tree resin, myrrh, a plant forever linked to the New Testament, may lower cholesterol according to a rat study.
NutraIngredients-USA.com put on its statistics hardhat to mine our mainframe for those stories that had the biggest impact on you, our readers, this year.
EFSA health claim opinion
The European Food Safety Authority (EFSA) has dismissed a second article 14 urinary tract infection (UTI)-cranberry extract health claim.
A new study demonstrates that the Food and Drug Administration (FDA) has scored a policy success through getting the dosage for folic acid fortification of flour right in the US, and any excessive intake is people is due to supplement usage, according to...
As the old year draws to a close, we review the significant waypoints of 2009 and look ahead to what is likely to dominate next year’s news. Join us now for a whistle-stop tour of the news topics that made the headlines on our flagship food and nutrition...
As the old year draws to a close, we review the significant waypoints of 2009 and look ahead to what is likely to dominate next year’s news. Join us now for a whistle-stop tour of the news topics that made the headlines on our flagship food and nutrition...
DSHEA turns 15
In the fifth and final installment of this DSHEA special, Frank Jaksch, the president and chief executive officer of Californian-based botanicals reference provider, Chromadex, outlines why he thinks current GMP inspection methodologies are unlikely to...